Richard L. Lindstrom M.D., Director at OCULAR THERAPEUTIX, INC (OCUL), bought 10,000 shares at $6.96 ($70K) on 2025-05-08, disclosed to the SEC on 2025-05-12.
Open-market purchase of $70k OCUL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| HROW | SELL | 2021-09-27 | $39K | — | Filing → |
| HROW | SELL | 2021-09-17 | $363K | — | Filing → |
| HROW | SELL | 2021-05-21 | $108K | — | Filing → |